TY - JOUR
T1 - Docking simulations, synthesis, and anti-inflammatory activity evaluation of 2-(N-alkyl)amino-3-nitroimidazo[1,2-a]pyridines
AU - Márquez-Flores, Yazmín K.
AU - Campos-Aldrete, Ma Elena
AU - Salgado-Zamora, Héctor
AU - Correa-Basurto, José
AU - Meléndez-Camargo, Ma Estela
N1 - Funding Information:
Acknowledgment This study was partially supported by the Sec-retaría de Investigación y de Posgrado, COFAA, (IPN). ICyTDF and CONACYT Grant No. 49937, 62488, 91426.
PY - 2012/6
Y1 - 2012/6
N2 - A set of imidazo[1,2-a]pyridine derivatives was submitted to a docking analysis on COX-1 and COX-2. Although most of the compounds showed affinity for both COX-1 and COX-2, compound 1h showed a higher COX-1 affinity while 1i was more selective to COX-2. None of them had ΔG value higher than indomethacin. Compounds 1b, 1c, and 1g were synthesized and evaluated as potential anti-inflammatory agents. Compound 2-(N-cyclopropyl) amino-3-nitroimidazo[1,2-a]pyridine (1c) which gave a very poor affinity for either COX-1 or COX-2, showed anti-inflammatory activity (20 mg/kg) on the cotton pellet granuloma bioassay, with no induction of gastrointestinal damage.
AB - A set of imidazo[1,2-a]pyridine derivatives was submitted to a docking analysis on COX-1 and COX-2. Although most of the compounds showed affinity for both COX-1 and COX-2, compound 1h showed a higher COX-1 affinity while 1i was more selective to COX-2. None of them had ΔG value higher than indomethacin. Compounds 1b, 1c, and 1g were synthesized and evaluated as potential anti-inflammatory agents. Compound 2-(N-cyclopropyl) amino-3-nitroimidazo[1,2-a]pyridine (1c) which gave a very poor affinity for either COX-1 or COX-2, showed anti-inflammatory activity (20 mg/kg) on the cotton pellet granuloma bioassay, with no induction of gastrointestinal damage.
KW - Anti-inflammatory
KW - Cyclooxygenase
KW - Docking
KW - Imidazo[1,2-a]pyridines
UR - http://www.scopus.com/inward/record.url?scp=84861918771&partnerID=8YFLogxK
U2 - 10.1007/s00044-011-9585-5
DO - 10.1007/s00044-011-9585-5
M3 - Artículo
SN - 1054-2523
VL - 21
SP - 775
EP - 782
JO - Medicinal Chemistry Research
JF - Medicinal Chemistry Research
IS - 6
ER -